Stay updated on Pembrolizumab for ALL MRD Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.

Latest updates to the Pembrolizumab for ALL MRD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removed older maintenance notices (v3.4.1) on the page, which are site-wide versioning updates rather than changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the site revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a Show glossary option and updated footer metadata to include Last Update Submitted that Met QC Criteria and Revision: v3.4.0, while removing the older labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page; this appears to be a backend/content-management update with no changes to the study details.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a new Locations section showing Seattle, Washington as a study site. Removed the Washington Locations entry and HHS Vulnerability Disclosure footer item; page revision updated to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedA new note states that publications are automatically filled from PubMed and the page now shows revision v3.3.2, replacing the previous wording and revision v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for ALL MRD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.